William Richards
Corporate Officer/Principal bij 23ANDME HOLDING CO.
Vermogen: 343 959 $ op 31-03-2024
Profiel
William Richards is currently the Vice President-Drug Discovery at 23andMe, Inc. and 23andMe Holding Co. He previously worked as the Executive Director-Research at Amgen, Inc. from 1996 to 2019.
Additionally, he served as the Chief Scientific Officer at Nura Bio, Inc. Dr. Richards holds a doctorate degree from Stony Brook University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-02-2024 | 646 540 ( 0.20% ) | 343 959 $ | 31-03-2024 |
Actieve functies van William Richards
| Bedrijven | Functie | Begin |
|---|---|---|
| 23ANDME HOLDING CO. | Corporate Officer/Principal | - |
23andMe, Inc.
 23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01-01-2020 |
Eerdere bekende functies van William Richards
| Bedrijven | Functie | Einde |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01-01-2019 |
Nura Bio, Inc.
 Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Opleiding van William Richards
| Stony Brook University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| 23ANDME HOLDING CO. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
23andMe, Inc.
23andMe, Inc. Medical SpecialtiesHealth Technology 23andMe, Inc. provides genetic information using DNA analysis technologies and web-based interactive tools. It enables individuals to gain deeper insights into personal ancestry, genealogy, and inherited traits. The company was founded by Linda Avey, Paul L. Cusenza and Anne E. Wojcicki in 2006 and is headquartered in Sunnyvale, CA. | Health Technology |
Nura Bio, Inc.
Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Health Technology |
